Page 92 - Control Theory in Biomedical Engineering
P. 92

78    Control theory in biomedical engineering


          and physiological variables are combined with a recursive subspace-based
          system identification approach to obtain the glycemic models. The recur-
          sively identified models can describe better the dynamic behavior of
          BGC variations in the human body over wide ranges of real-world condi-
          tions and make accurate short-term predictions of glucose concentration
          measurements. The AL-MPC algorithm developed by using these adaptive
          models computes the optimal amount of insulin for AP systems without
          requiring any manual information on meal and PA specifications. Using
          machine-learning techniques and patients’ historical data, the key control
          parameters are modified in advance for the anticipated periods of disturbance
          effects such as exercise. The proposed PMM-AP could be a reliable step
          toward improved glycemic control by individualizing the insulin computa-
          tions and reducing the risk of postexercise hypoglycemia in the next
          generation of AP algorithms.



          Acknowledgments

          This work is supported by the National Institutes of Health under grants 1DP3DK101077-01
          and 1DP3DK101075-01, and JDRF award 2-SRA-2017-506-M-B made possible by fund-
          ing provided through the collaboration between JDRF and The Leona M. and Harry B.
          Helmsley Charitable Trust.



          References

          Behbehani, K., Cross, R.R., 1991. A controller for regulation of mean arterial blood pressure
             using optimum nitroprusside infusion rate. IEEE Trans. Biomed. Eng. 38 (6), 513–521.
          Bekiari, E., Kitsios, K., Thabit, H., Tauschmann, M., Athanasiadou, E., Karagiannis, T.,
             Haidich, A.-B., Hovorka, R., Tsapas, A., 2018. Artificial pancreas treatment for
             outpatients with type 1 diabetes: systematic review and meta-analysis. BMJ 361, k1310.
          Boiroux, D., Duun-Henriksen, A.K., Schmidt, S., Nørgaard, K., Madsbad, S.,
             Poulsen, N.K., Madsen, H., Jørgensen, J.B., 2018. Overnight glucose control in people
             with type 1 diabetes. Biomed. Signal Process. Control 39, 503–512.
          Cameron, F., Bequette, B.W., Wilson, D.M., Buckingham, B.A., Lee, H., Niemeyer, G.,
             2011. A closed-loop artificial pancreas based on risk management. J. Diabetes Sci.
             Technol. 5 (2), 368–379.
          Chakrabarty, A., Zavitsanou, S., Doyle, F.J., Dassau, E., 2018. Event-triggered model pre-
             dictive control for embedded artificial pancreas systems. IEEE Trans. Biomed. Eng.
             65 (3), 575–586.
          Clarke, W.L., Anderson, S., Breton, M., Patek, S., Kashmer, L., Kovatchev, B., 2009.
             Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery
             and a model predictive control algorithm: the Virginia experience. J. Diabetes Sci.
             Technol. 3 (5), 1031–1038.
          Cooke, D.W., Plotnick, L., 2008. Type 1 diabetes mellitus in pediatrics. Pediatr. Rev.
             29 (11), 374–384.
   87   88   89   90   91   92   93   94   95   96   97